Trabodenoson
- Generic Name
- Trabodenoson
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C15H20N6O6
- CAS Number
- 871108-05-3
- Unique Ingredient Identifier
- 1T237110W4
- Background
Trabodenoson has been used in trials studying the treatment of Ocular Hypertension (OHT) and Primary Open-Angle Glaucoma (POAG).
- Associated Conditions
- -
- Associated Therapies
- -
A Phase II Study to Evaluate the Additivity of Trabodenoson to Latanoprost in Adults With Ocular Hypertension or Primary Open-Angle Glaucoma
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2013-08-06
- Last Posted Date
- 2017-12-02
- Lead Sponsor
- Inotek Pharmaceuticals Corporation
- Target Recruit Count
- 101
- Registration Number
- NCT01917383
- Locations
- 🇺🇸
Chiltern, Bristol, Tennessee, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath